Article
Co-crystalization and in vitro biological characterization of 5-aryl-4-(5-substituted-2-4-dihydroxyphenyl)-1,2,3-thiadiazole Hsp90 inhibitors.
PloS one - 1 Jan 2012
Sharp Swee Y, Roe S Mark, Kazlauskas Egidijus, Cikotienė Inga, Workman Paul, Matulis Daumantas, Prodromou Chrisostomos
Abstract excerpt
A potential therapeutic strategy for targeting cancer that has gained much interest is the inhibition of the ATP binding and ATPase activity of the molecular chaperone Hsp90. We have determined the structure of the human Hsp90α N-terminal domain in complex with a series of 5-aryl-4-(5-substituted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
